国际肿瘤学杂志 ›› 2026, Vol. 53 ›› Issue (1): 24-30.doi: 10.3760/cma.j.cn371439-20250719-00003

• 论著 • 上一篇    下一篇

CONUT评分联合血清TLR-4、NF-κB预测胸部恶性肿瘤放疗患者放射性肺损伤的价值

雷胜飞(), 邱俊, 王建礼   

  1. 湖南省人民医院(湖南师范大学附属第一医院)肿瘤科,长沙 410005
  • 收稿日期:2025-07-19 出版日期:2026-01-08 发布日期:2026-01-13
  • 通讯作者: 雷胜飞,Email: hjhhhj555@163.com
  • 基金资助:
    湖南省自然科学基金(2024JJ9299)

Predictive value of CONUT score combined with serum TLR-4 and NF-κB for radiation-induced lung injury in patients with thoracic malignancies undergoing radiotherapy

Lei Shengfei(), Qiu Jun, Wang Jianli   

  1. Department of Oncology, People's Hospital of Hunan Province (First Affiliated Hospital of Hunan Normal University), Changsha 410005, China
  • Received:2025-07-19 Online:2026-01-08 Published:2026-01-13
  • Supported by:
    Natural Science Foundation of Hunan Province of China(2024JJ9299)

摘要:

目的 探讨控制营养状态(CONUT)评分联合血清Toll样受体-4(TLR-4)、核转录因子κB(NF-κB)预测胸部恶性肿瘤放疗患者放射性肺损伤的价值。方法 选取2023年6月—2024年6月于湖南省人民医院进行放疗的胸部恶性肿瘤(食管癌、非小细胞肺癌)患者共86例为研究对象,放疗均持续6~7周,于放疗前、放疗3周后、放疗结束时分别进行血清TLR-4、NF-κB检测及CONUT评分评估。放疗结束1个月后根据是否继发放射性肺损伤将患者分为损伤组和非损伤组,比较两组患者放疗前、后各指标差异,采用Pearson相关性分析评估CONUT评分与血清TLR-4、NF-κB水平相关性,并采用logistic回归和受试者操作特征(ROC)曲线分析评估不同时期各指标预测放射性肺损伤的价值。结果 放疗结束1个月后,86例患者经评估有21例发生放射性肺损伤纳入损伤组,65例未发生者纳入未损伤组。损伤组患者吸烟史(χ2=5.18,P=0.023)、联合化疗(χ2=4.57,P=0.033)、放疗剂量≥60 Gy(χ2=4.59,P=0.032)占比均高于非损伤组。放疗前,损伤组CONUT评分与血清TLR-4、NF-κB水平分别为(2.65±0.83)分、(36.54±4.26)ng/L、(14.19±2.69)ng/L,与非损伤组的(2.21±0.96)分、(37.12±4.93)ng/L、(14.26±1.36)ng/L比较,差异均无统计学意义(t=1.88,P=0.063;t=0.48,P=0.630;t=0.16,P=0.875);放疗3周后,损伤组患者CONUT评分与血清TLR-4、NF-κB水平分别为(3.98±1.24)分、(49.26±5.17)ng/L、(17.59±3.25)ng/L,均高于非损伤组的(3.25±1.02)分、(42.86±5.12)ng/L、(15.14±2.29)ng/L(t=2.70,P=0.008;t=4.97,P<0.001;t=3.83,P<0.001);放疗结束时,损伤组患者CONUT评分与血清TLR-4、NF-κB水平分别为(5.27±1.47)分、(53.57±6.95)ng/L、(19.66±2.16)ng/L,均高于非损伤组的(3.51±1.09)分、(44.16±4.19)ng/L、(17.34±1.18)ng/L(t=5.89,P<0.001;t=7.52,P<0.001;t=6.28,P<0.001);两组患者放疗3周后和放疗结束时的CONUT评分与血清TLR-4、NF-κB水平均较放疗前升高(均P<0.05)。Pearson相关性分析显示,放疗3周后及放疗结束时CONUT评分与血清TLR-4、NF-κB水平均呈正相关(r=0.53,P<0.001,r=0.44,P<0.001;r=0.57,P<0.001,r=0.47,P<0.001)。logistic回归分析显示,校正混杂因素后,放疗3周后和放疗结束时CONUT评分(OR=5.73,95%CI为2.09~15.76,P=0.001;OR=6.40,95%CI为2.33~17.59,P<0.001)与血清TLR-4(OR=6.51,95%CI为2.37~17.91,P<0.001;OR=7.07,95%CI为2.57~19.44,P<0.001)、NF-κB(OR=5.75,95%CI为2.09~15.81,P=0.001;OR=6.33,95%CI为2.30~17.42,P<0.001)水平均是胸部恶性肿瘤放疗患者发生放射性肺损伤的独立预测因素。ROC曲线分析显示,放疗3周后和放疗结束时CONUT评分(AUC分别为0.69、0.86)与血清TLR-4(AUC分别为0.77、0.89)、NF-κB(AUC分别为0.69、0.73)水平单项和联合(AUC分别为0.90、0.97)均具有预测胸部恶性肿瘤放疗患者发生放射性肺损伤的价值,且放疗3周后和放疗结束时联合检测的AUC均较单项指标更高,放疗结束时指标联合检测的AUC高于放疗3周后(均P<0.05)。结论 放疗3周后和放疗结束时的CONUT评分与血清TLR-4、NF-κB水平均具有预测胸部恶性肿瘤放疗患者发生放射性肺损伤的价值,且放疗结束时指标联合检测的效能更高。

关键词: 胸部肿瘤, Toll样受体4, NF-κB, 营养评价, 预测, 放射性肺损伤

Abstract:

Objective To explore the predictive value of controlling nutritional status (CONUT) score combined with serum Toll-like receptor-4 (TLR-4) and nuclear factor-κB (NF-κB) for radiation-induced lung injury in patients with thoracic malignancies undergoing radiotherapy. Methods A total of 86 patients with thoracic malignancies (esophageal cancer, non-small cell lung cancer) undergoing radiotherapy for 6-7 weeks in People's Hospital of Hunan Province between June 2023 and June 2024 were selected as the research objects. Before radiotherapy, after 3 weeks of radiotherapy and at the end of radiotherapy, detection of serum TLR-4 and NF-κB, and evaluation of CONUT score were performed. At 1 month after radiotherapy, patients were divided into injury group and non-injury group according to presence or absence of radiation-induced lung injury, and differences in all indicators before and after radiotherapy were compared between the two groups. The correlation between CONUT score and serum TLR-4, NF-κB levels was evaluated by Pearson correlation analysis, and predictive value of each indicator for radiation-induced lung injury in different periods was evaluated by logistic regression and receiver operator characteristic (ROC) curve analysis. Results In the 86 patients at 1 month after radiotherapy, there were 21 cases with radiation-induced lung injury (injury group) and 65 cases without injury (non-injury group). The proportions of smoking history (χ2=5.18, P=0.023), combined chemotherapy (χ2=4.57, P=0.033) and radiotherapy dose ≥60 Gy (χ2=4.59, P=0.032) in injury group were higher than those in non-injury group. Before radiotherapy, there were no statistically significant differences in CONUT score [(2.65±0.83) points vs. (2.21±0.96) points] and levels of serum TLR-4 [(36.54±4.26) ng/L vs. (37.12±4.93) ng/L] and NF-κB [(14.19±2.69) ng/L vs. (14.26±1.36) ng/L] between injury group and non-injury group (t=1.88, P=0.063; t=0.48, P=0.630; t=0.16, P=0.875). After 3 weeks of radiotherapy, CONUT score [(3.98±1.24) points vs. (3.25±1.02) points] and levels of serum TLR-4 [(49.26±5.17) ng/L vs. (42.86±5.12) ng/L] and NF-κB [(17.59±3.25) ng/L vs. (15.14±2.29) ng/L] were higher in injury group than non-injury group (t=2.70, P=0.008; t=4.97, P<0.001; t=3.83, P<0.001). At the end of radiotherapy, CONUT score [(5.27±1.47) points vs. (3.51±1.09) points] and levels of serum TLR-4 [(53.57±6.95) ng/L vs. (44.16±4.19) ng/L] and NF-κB [(19.66±2.16) ng/L vs. (17.34±1.18) ng/L] were higher in injury group than non-injury group (t=5.89, P<0.001; t=7.52, P<0.001; t=6.28, P<0.001), and all the three indicators of the two groups of patients at 3 weeks after radiotherapy and at the end of radiotherapy were all higher than those before radiotherapy (all P<0.05). Pearson correlation analysis showed that CONUT score was positively correlated with the levels of serum TLR-4 and NF-κB at 3 weeks after radiotherapy and at the end of radiotherapy (r=0.53, P<0.001, r=0.44, P<0.001; r=0.57, P<0.001, r=0.47, P<0.001). After correcting for confounding factors, logistic regression analysis showed that CONUT score at 3 weeks after radiotherapy (OR=5.73, 95%CI: 2.09-15.76, P=0.001) and at the end of radiotherapy (OR=6.40, 95%CI: 2.33-17.59, P<0.001), along with the levels of serum TLR-4 (OR=6.51, 95%CI: 2.37-17.91, P<0.001; OR=7.07, 95%CI: 2.57-19.44, P<0.001) and NF-κB (OR=5.75, 95%CI: 2.09-15.81, P=0.001; OR=6.33, 95%CI: 2.30-17.42, P<0.001) were all independent factors for predicting radiation-induced lung injury in patients with thoracic malignancies undergoing radiotherapy. ROC curve analysis demonstrated that CONUT score at 3 weeks after radiotherapy (AUC=0.69) and at the end of radiotherapy (AUC=0.86), along with serum levels of TLR-4 (AUC=0.77 and 0.89, respectively) and NF-κB (AUC=0.69 and 0.73, respectively), both individually and in combination (AUC=0.90 and 0.97, respectively), exhibited predictive value for radiation-induced lung injury in patients with thoracic malignancies undergoing radiotherapy. Furthermore, the AUC values of combined indicators at 3 weeks after radiotherapy and at the end of radiotherapy were higher than those of individual indicator alone. The AUC values of combined indicators at the end of radiotherapy exceeded those obtained at 3 weeks after radiotherapy (all P<0.05). Conclusions The CONUT score at 3 weeks after radiotherapy and at the end of radiotherapy, as well as the levels of serum TLR-4 and NF-κB, all have predictive value for radiation-induced lung injury in patients with thoracic malignancies undergoing radiotherapy, and the predictive efficacy of combined detection with the above indicators at the end of radiotherapy is higher.

Key words: Thoracic neoplasms, Toll-like receptor 4, NF-kappa B, Nutrition assessment, Forecasting, Radiation-induced lung injury